Literature DB >> 22993626

Serum harvested from heifers one month post-zeranol implantation stimulates MCF-7 breast cancer cell growth.

Weiping Ye1, Pingping Xu, Saiyi Zhong, Walter R Threlfall, Christopher Frasure, Eric Feng, Hong Li, Shu-Hong Lin, Jie-Yu Liu, Young C Lin.   

Abstract

Breast cancer is a serious disease in the US. Numerous risk factors have been linked to this disease. The safety of using growth promoters, such as zeranol, remains under debate due to the lack of sufficient in vitro and in vivo evidence. Using CellTiter 96(™) Aqueous Non-Radioactive Cell Proliferation assay, real-time PCR and Western blot analysis, we evaluated the effects of sera harvested from experimental and control heifers before and after one month of zeranol implantation on the growth of human breast cancer cell line MCF-7 as well as the involved mechanisms. We found that sera harvested from the heifers following one month of zeranol implantation were more mitogenically potent in stimulating the proliferation of MCF-7 cells when compared to sera harvested from the same heifers before zeranol implantation and the control heifers. Further investigation found that dextran-coated charcoal suppressed the stimulating effect of the sera on MCF-7 cell growth. The mechanisms involved in the MCF-7 cell proliferation stimulated by zeranol-containing sera may include up-regulation of cyclin D1 and down-regulation of p53 and p21 expression at the mRNA and protein levels in the cells. The results suggest that the consumption of beef products containing biologically active residues of zeranol or its metabolites is a risk linked to breast cancer development. Further investigation is required in order to clarify this critical issue.

Entities:  

Year:  2010        PMID: 22993626      PMCID: PMC3446733          DOI: 10.3892/etm.2010.155

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  28 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Expression of cyclin D1 and retinoblastoma protein in Paget's disease of the vulva and breast: an immunohistochemical study of 108 cases.

Authors:  Patricia E Ellis; Allan B Maclean; Julie C Crow; L F Wong Te Fong; Kerstin J Rolfe; Christopher W Perrett
Journal:  Histopathology       Date:  2009-12       Impact factor: 5.087

3.  Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells.

Authors:  Soma Mandal; James R Davie
Journal:  J Cell Physiol       Date:  2010-07       Impact factor: 6.384

4.  Red meat consumption during adolescence among premenopausal women and risk of breast cancer.

Authors:  Eleni Linos; Walter C Willett; Eunyoung Cho; Graham Colditz; Lindsay A Frazier
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07-31       Impact factor: 4.254

5.  Growth, feed efficiency and variation of individually fed Angus, polled Hereford and Holstein steers.

Authors:  M L Thonney
Journal:  J Anim Sci       Date:  1987-07       Impact factor: 3.159

6.  Estrogenic down-regulation of protein tyrosine phosphatase gamma (PTP gamma) in human breast is associated with estrogen receptor alpha.

Authors:  Suling Liu; Yasuro Sugimoto; Samuel K Kulp; Jiahua Jiang; Hsiang-Lin Chang; Kah-Young Park; Yoko Kashida; Young C Lin
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

7.  Randomised trial of high doses of stilboestrol and ethisterone in pregnancy: long-term follow-up of mothers.

Authors:  V Beral; L Colwell
Journal:  Br Med J       Date:  1980-10-25

Review 8.  Risk factors and risk reduction of breast and ovarian cancer.

Authors:  Cecile T M Brekelmans
Journal:  Curr Opin Obstet Gynecol       Date:  2003-02       Impact factor: 1.927

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Mitogenic activity of zeranol in human breast cancer cells is enhanced by leptin and suppressed by gossypol.

Authors:  Pingping Xu; Weiping Ye; Robert Jen; Shu-Hong Lin; Chieh-Ti Kuo; Young C Lin
Journal:  Anticancer Res       Date:  2009-11       Impact factor: 2.480

View more
  2 in total

Review 1.  State of the evidence 2017: an update on the connection between breast cancer and the environment.

Authors:  Janet M Gray; Sharima Rasanayagam; Connie Engel; Jeanne Rizzo
Journal:  Environ Health       Date:  2017-09-02       Impact factor: 5.984

2.  Zeranol down-regulates p53 expression in primary cultured human breast cancer epithelial cells through epigenetic modification.

Authors:  Weiping Ye; Pingping Xu; Robert Jen; Eric Feng; Saiyi Zhong; Hong Li; Shu-Hong Lin; Jie-Yu Liu; Young C Lin
Journal:  Int J Mol Sci       Date:  2011-02-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.